<DOC>
	<DOCNO>NCT00102817</DOCNO>
	<brief_summary>This trial conduct United States America ( USA ) . This 12 month study determine Norditropin safe effective child IGF deficiency .</brief_summary>
	<brief_title>Somatropin ( Norditropin ) Insulin-like Growth Factor ( IGF ) Deficient Children</brief_title>
	<detailed_description />
	<mesh_term>Dwarfism</mesh_term>
	<mesh_term>Dwarfism , Pituitary</mesh_term>
	<criteria>Ages 315 Presence growth failure indicate height standard deviation score less equal 2 Body mass index great equal 25th percentile height age IGF concentration less equal 33rd percentile</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>13 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Growth Hormone Disorder</keyword>
</DOC>